Potentially inappropriate medication use among older adults in the USA in 2007

Age and Ageing

Volumn 40, Issue 3, 2011, Pages 398-401

  Zhang, Yan Jun ^a   Liu, Wei Wei ^b   Wang, Jing Bo ^c   Guo, Jeff J ^a  

^a UNIVERSITY OF CINCINNATI ACADEMIC HEALTH CENTER   (United States)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c 309TH HOSPITAL OF PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DEXTROPROPOXYPHENE; DIGESTIVE TRACT SPASMOLYTIC AGENT; INDOMETACIN; LONG ACTING DRUG; MUSCLE RELAXANT AGENT; PROMETHAZINE; SPASMOLYTIC AGENT;

AGE; AGED; DRUG UTILIZATION; EDUCATIONAL STATUS; GEOGRAPHIC DISTRIBUTION; HEALTH STATUS; HUMAN; INAPPROPRIATE PRESCRIBING; INCOME; LETTER; POLYPHARMACY; PRIORITY JOURNAL; RISK FACTOR; SELF EVALUATION; SEX DIFFERENCE; UNITED STATES;

AGED; AGED, 80 AND OVER; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; MEDICATION ERRORS; RESIDENCE CHARACTERISTICS; RISK FACTORS; UNITED STATES;

EID: 79955407939     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afr012     Document Type: Letter

References (20)

1. Fick DM, Cooper JW, Wade WE et al Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-24.
2. Zhan C, Sangl J, Bierman AS et al Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001; 286: 2823-9.
3. Barnett MJ, Perry PJ, Langstaff JD, Kaboli PJ. Comparison of rates of potentially inappropriate medication use according to the Zhan criteria for VA versus private sector medicare HMOs. J Manag Care Pharm 2006; 12: 362-70.
4. Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008; 37: 673-9.
5. Fiss T, Dreier A, Meinke C et al Frequency of inappropriate drugs in primary care: analysis of a sample of immobile patients who received periodic home visits. Age Ageing 2011; 40: 66-73.
6. US Agency for Healthcare Research and Quality. 2003-2009 National Healthcare Quality and Disparities Reports. Available at: http://www.ahrq.gov/qual/measurix.htm.
7. Klein RJ, Proctor SE, Boudreault MA, Turczyn KM. Healthy People 2010 Criteria for Data Suppression. Healthy People 2010 Stat Notes 2002: 1-12.
8. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994; 272: 292-6.
9. Kaur S, Mitchell G, Vitetta L, Roberts MS. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging 2009; 26: 1013-28.
10. Briesacher B, Limcangco R, Simoni-Wastila L, Doshi J, Gurwitz J. Evaluation of nationally mandated drug use reviews to improve patient safety in nursing homes: a natural experiment. J Am Geriatr Soc 2005; 53: 991-6.
11. Pugh MJ, Hanlon JT, Zeber JE et al Assessing potentially inappropriate prescribing in the elderly veterans affairs population using the HEDIS 2006 quality measure. J Manag Care Pharm 2006; 12: 537-45.
12. Stuart B, Kamal-Bahl S, Briesacher B et al Trends in the prescription of inappropriate drugs for the elderly between 1995 and 1999. Am J Geriatr Pharmacother 2003; 1: 61-74.
13. Kamal-Bahl S, Stuart BC, Beers MH. National trends in and predictors of propoxyphene use in community-dwelling older adults. Am J Geriatr Pharmacother 2005; 3: 186-95.
14. Aschenbrenner DS. FDA raises safety issues concerning propoxyphene. Am J Nurs 2010; 110: 59-60.
15. Bateman ND, Sandilands EA. European Medicines Evaluation Agency bans dextropropoxyphene: a landmark decision for clinical toxicology? Clin Toxicol (Phila) 2009; 47: 782-3.
16. US Food and Drug Administration. Propoxyphene: Withdrawal-Risk of Cardiac Toxicity. 19 November 2010. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm234389.htm.
17. Avorn J. Improving drug use in elderly patients: getting to the next level. JAMA 2001; 286: 2866-8.
18. Fialova D, Topinkova E, Gambassi G et al Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293: 1348-58.
19. Levy HB, Marcus EL, Christen C. Beyond the Beers criteria: a comparative overview of explicit criteria. Ann Pharmacother 2010; 44: 1968-75.
20. Lang PO, Hasso Y, Drame M et al Potentially inappropriate prescribing including under-use amongst older patients with cognitive or psychiatric co-morbidities. Age Ageing 2010; 39: 373-81.